European Medicines Agency’s Management Board nominates Guido Rasi as Executive Director

EMA

1 October 2015 - The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. At an extraordinary session on 1 October, the Board selected Professor Rasi from a shortlist of candidates provided by the European Commission.

Professor Rasi has been invited to give a statement to the European Parliament’s Committee on the Environment, Public Health and Food SafetyExternal link icon (ENVI) on 13 October 2015. The appointment of the new Executive Director will only be made after this session.

An information sheet explaining the process for the appointment of the EMA Executive Director is available. A photo and biography of Professor Rasi are also available.

Following his nomination, Professor Rasi said, “I am honoured to have been nominated as EMA’s Executive Director and am grateful for the opportunity to continue our efforts to make the Agency fit for the challenges ahead. I am enormously proud of the Agency and its network. Looking to the future, we must continue to meet patients’ legitimate expectations for access to new and safe therapeutic options. This requires that the medicines authorisation process not only supports the early stages of research and development, but also strives to make the best possible use of real world data throughout a medicine’s lifecycle.”

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002407.jsp&mid=WC0b01ac058004d5c1

Michael Wonder

Posted by:

Michael Wonder